In the article by Barchiesi et al (Barchiesi F, Lucchinetti E, Zaugg M, Ogunshola OO, Wright M, Meyer M, Rosselli M, Schaufelberger S, Gillespie DG, Jackson EK, Dubey RK. Candidate genes and mechanisms for 2-methoxyestradiol–mediated vasoprotection. Hypertension. 2010;56:964–972, doi: 10.1161/HYPERTENSIONAHA.110.152298), which published online ahead of print October 4, 2010, and appeared in the November 2010 issue of the journal, a correction was needed.
In Figure 1B, the effects of 2-ME on Cyclin B1 were mistakenly illustrated as a dose-response. This should have been a time-response (exactly like that for the adjacent image for Cyclin D1). The corrected panel B of Figure 1 is shown below.
The authors apologize for this error.
This correction has been made to the current online version of the article, which is available at http://hyper.ahajournals.org/content/56/5/964.full.
- © 2016 American Heart Association, Inc.